Grants/Awards
Overview of grants and awards received by our research group during the last few years.
Main content
2024 | 听 |
| 听 | Oleksii Nikolaienko, researcher at Mohn Cancer Research Laboratory, received funding from "The Norwegian Cancer Society Pioneer Projects" for the project: "Low-level epimutational mosaicism in tumour suppressor genes - a generic cancer risk factor".听 
Photo:
Kreftforeningen
|
2023 | 听 |
| 听 | ) Andreas Venizelos, former听postdoc. at Mohn Cancer Research Laboratory, received an award听for "Paper of the year" in the medical journal听Endocrine-Related Cancer, on behalf of the co-authors, for the article:听"". The award was presented at the SfE BES in Glasgow on听15th听November 2023. 
Photo:
Mohn kreftforskningslaboratorium
|
| 听 | Nora D. Hatletvedt, enrolled in the Medical Student Research Programme at Mohn Cancer Research Laboratory, received a prize for "Best presentation" with her presentation: "MDM2 polymorphisms and bone marrow recovery in breast cancer patients during neoadjuvant chemotherapy". 
Photo:
幸运飞艇计划
|
| 听 | Research School in Clinical Medicine at 幸运飞艇计划 - Prize for best poster Christina Engebrethsen, PhD student at Mohn Cancer Research Laboratory, received a prize for the 1st place in the category "Best poster" with her poster: "Homologous recombination deficiency in breast cancer". 
Photo:
幸运飞艇计划
|
2022 | 听 |
| 听 | Wei Deng, researcher at Mohn Cancer Research Laboratory, received funding from "The Norwegian Cancer Society Pioneer Projects" for the project: "A new method for measuring cell division for more personalized cancer treatment".听
Photo:
Kreftforeningen
|
| 听 | - "Epimutations in MGMT and MLH1 and risk of cancers of the colon, endometrium and glioblastomas" (Per Eystein L酶nning). -听"Predictive markers in Her2-positive breast cancer" (Stian Knappskog). 
Photo:
Helse Vest
|
| 听 | 听(extension) - "Identifying genomic alterations predicting response to neoadjuvant endocrine therapy" (Hans Petter Eikesdal).
Photo:
Helse Vest
|
| 听 | -听"Is BRCA1-methylation in early embryonic life the first step towards cancer?" (Stian Knappskog). 
Photo:
Kreftforeningen
|
| 听 | Nigar Sofiyeva, MD, the final year PhD student at K.G. Jebsen Center for Genome-Directed Cancer Therapy and Mohn Cancer Research Laboratory at the University of Bergen, received the Meltzer Foundation Award 2022. The prize was awarded by The Meltzer Research Fund and is assigned to PhD. candidates and graduate students meeting 鈥淢eltzer quality鈥� requirements as support for the academic project. Dr. Sofiyeva has received the maximum allocated amount of 75,000 NOK, and her research project aims to evaluate the regulatory mechanisms of driver genes in breast cancer.听 
Photo:
幸运飞艇计划/Mohn kreftforskningslaboratorium
|
| 2021 | 听 |
| 听 | 听(extension) Extension of project grant linked to the听"K.G. Jebsen Center for Genome-Directed Cancer Therapy". 
Photo:
Stiftelsen Kristian Gerhard Jebsen
|
| 听 | -听"Personalized treatment based on gene analysis of hormone-sensitive breast cancer" (Hans Petter Eikesdal). -听"Immune-related mechanisms by anti-Her2 treatment" (Stian Knappskog).
Photo:
Kreftforeningen
|
| 听 | 听 -听"Identifying genomic alterations predicting response to neoadjuvant endocrine therapy" (Hans Petter Eikesdal).
Photo:
Helse Vest
|
| 2019 | 听 |
| 听 | -听"Normal Cell BRCA1 methylation and risk of Breast- and Ovarian Cancer" (Per Eystein L酶nning). -听"Molecular mechanisms dictating chemoresistance in patients with breast cancer" (Stian Knappskog).
Photo:
Helse Vest
|
| 听 | Award from The Medical Faculty at 幸运飞艇计划 - "Research group of the year" The Breast Cancer Group led by Per Eystein L酶nning, Clinical institute 2 (K2), received the award for "research group of the year" at the Medical Faculty. Jury reasoning: This years award for best research group goes to the Breast Cancer Group at K2, led by professor Per Eystein L酶nning. The group has for many years produced high quality research and contributed to groundbreaking scientific findings in the breast cancer field. The group has also been running the Mohn Cancer Laboratory and published frequently in high impact journals like Cancer Cell, Plos genetics, Nature Medicine, as well as Annals of Internal Medicine. Good access to external financing has enabled to group to contribute to building up the good cancer research environment here at the faculty. 
Photo:
J酶rgen Barth - Per Eystein L酶nning mottar prisen for 氓rets forskningsgruppe.
|
| 2018 | 听 |
| 听 | "Targeted therapy of triple negative breast cancer - from lab to patient care" (Hans Petter Eikesdal).听
Photo:
Helse Vest
|
| 听 | 听听 The Breast Cancer Group, led by Per Eystein L酶nning, received financial support from the foundation to establish the听"K.G. Jebsen Center for Genome-Directed Cancer Therapy". The new center consists of researchers and clinicians from 幸运飞艇计划 and the Cancer Department at Haukeland University Hospital, in addition to pathologists and bioinformaticians from the Sanger Institute in Cambridge, England.听
Photo:
Stiftelsen Kristian Gerhard Jebsen
|
| 听 | The Norwegian Research Council - Free project support for medicine, health and biology (FRIMEDBIO) - (Stian Knappskog). - (Per Eystein L酶nning). 
Photo:
贵辞谤蝉办苍颈苍驳蝉谤氓诲别迟
|
听